These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37247330)

  • 1. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
    SCORE2 working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2439-2454. PubMed ID: 34120177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model.
    ; ; ; ;
    Eur Heart J; 2024 Sep; ():. PubMed ID: 39217477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.
    Matsushita K; Kaptoge S; Hageman SHJ; Sang Y; Ballew SH; Grams ME; Surapaneni A; Sun L; Arnlov J; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Jassal SK; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sairenchi T; Schaeffner E; Schneider MP; Shalev V; Shlipak MG; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AY; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Dorresteijn JAN; Di Angelantonio E; Visseren FLJ; Pennells L; Coresh J
    Eur J Prev Cardiol; 2023 Jan; 30(1):8-16. PubMed ID: 35972749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    SCORE2-OP working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2455-2467. PubMed ID: 34120185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.
    Hageman SHJ; Kaptoge S; de Vries TI; Lu W; Kist JM; van Os HJA; Numans ME; Läll K; Bobak M; Pikhart H; Kubinova R; Malyutina S; Pająk A; Tamosiunas A; Erbel R; Stang A; Schmidt B; Schramm S; Bolton TR; Spackman S; Bakker SJL; Blaha M; Boer JMA; Bonnefond A; Brenner H; Brunner EJ; Cook NR; Davidson K; Dennison E; Donfrancesco C; Dörr M; Floyd JS; Ford I; Fu M; Gansevoort RT; Giampaoli S; Gillum RF; Gómez-de-la-Cámara A; Håheim LL; Hansson PO; Harms P; Humphries SE; Ikram MK; Jukema JW; Kavousi M; Kiechl S; Kucharska-Newton A; Pablos DL; Matsushita K; Meyer HE; Moons KGM; Mortensen MB; Muilwijk M; Nordestgaard BG; Packard C; Pamieri L; Panagiotakos D; Peters A; Potier L; Providencia R; Psaty BM; Ridker PM; Rodriguez B; Rosengren A; Sattar N; Schöttker B; Schwartz JE; Shea S; Shipley MJ; Sofat R; Thorand B; Verschuren WMM; Völzke H; Wareham NJ; Westbury L; Willeit P; Zhou B; Danesh J; Visseren FLJ; Di Angelantonio E; Pennells L; Dorresteijn JAN
    Eur J Prev Cardiol; 2024 Oct; 31(14):1690-1699. PubMed ID: 38752762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe.
    Temtem M; Mendonça MI; Santos M; Sá D; Sousa F; Freitas S; Borges S; Henriques E; Rodrigues M; Soares C; Rodrigues R; Serrão M; Drumond A; Sousa AC; Palma Reis R
    Rev Port Cardiol; 2024 Aug; 43(8):437-444. PubMed ID: 38395299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
    Hageman SHJ; Petitjaen C; Pennells L; Kaptoge S; Pajouheshnia R; Tillmann T; Blaha MJ; McClelland RL; Matsushita K; Nambi V; Klungel OH; Souverein PC; van der Schouw YT; Verschuren WMM; Lehmann N; Erbel R; Jöckel KH; Di Angelantonio E; Visseren FLJ; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Oct; 30(15):1705-1714. PubMed ID: 37264679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
    van Trier TJ; Snaterse M; Boekholdt SM; Scholte Op Reimer WJM; Hageman SHJ; Visseren FLJ; Dorresteijn JAN; Peters RJG; Jørstad HT
    Eur J Prev Cardiol; 2024 Jan; 31(2):182-189. PubMed ID: 37793098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of glycated hemoglobin A
    Sinning C; Makarova N; Völzke H; Schnabel RB; Ojeda F; Dörr M; Felix SB; Koenig W; Peters A; Rathmann W; Schöttker B; Brenner H; Veronesi G; Cesana G; Brambilla P; Palosaari T; Kuulasmaa K; Njølstad I; Mathiesen EB; Wilsgaard T; Blankenberg S; Söderberg S; Ferrario MM; Thorand B
    Cardiovasc Diabetol; 2021 Nov; 20(1):223. PubMed ID: 34781939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods.
    Dong W; Wan EYF; Fong DYT; Tan KC; Tsui WW; Hui EM; Chan KH; Fung CSC; Lam CLK
    Diabetes Obes Metab; 2024 Sep; 26(9):3969-3987. PubMed ID: 39010291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records.
    Xu Z; Arnold M; Sun L; Stevens D; Chung R; Ip S; Barrett J; Kaptoge S; Pennells L; Di Angelantonio E; Wood AM
    Int J Epidemiol; 2022 Dec; 51(6):1813-1823. PubMed ID: 35776101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: an external validation study.
    Kist JM; Vos RC; Mairuhu ATA; Struijs JN; van Peet PG; Vos HMM; van Os HJA; Beishuizen ED; Sijpkens YWJ; Faiq MA; Numans ME; Groenwold RHH
    EClinicalMedicine; 2023 Mar; 57():101862. PubMed ID: 36864978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the European SCORE2 models in a Canadian primary care cohort.
    Sud M; Sivaswamy A; Austin PC; Abdel-Qadir H; Anderson TJ; Khera R; Naimark DMJ; Lee DS; Roifman I; Thanassoulis G; Tu K; Wijeysundera HC; Ko DT
    Eur J Prev Cardiol; 2024 Apr; 31(6):668-676. PubMed ID: 37946603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm.
    González-Salvatierra S; García-Martín A; García-Fontana B; Martínez-Heredia L; García-Fontana C; Muñoz-Torres M
    Cardiovasc Diabetol; 2024 Aug; 23(1):311. PubMed ID: 39182106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of 10-year cardiovascular disease risk by diabetes status and lipoprotein-a levels; the HellenicSCORE II.
    Panagiotakos D; Chrysohoou C; Pitsavos C; Tsioufis K
    Hellenic J Cardiol; 2024; 79():3-14. PubMed ID: 37913991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.